| Synonyms: | |
| Status: | Approved (2021) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 7K28NB895L |
| InChI Key | LOMMPXLFBTZENJ-ZACQAIPSSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H12F3NO4S |
| Molecular Weight | 383.35 |
| AlogP | 3.29 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 87.39 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 26.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Endothelial PAS domain-containing protein 1 inhibitor | ClinicalTrials Other Other |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
|
11-17 | 9 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Renal Cell | 4 | D002292 | ClinicalTrials |
| Carcinoma, Renal Cell | 4 | D002292 | ClinicalTrials |
| Neuroendocrine Tumors | 4 | D018358 | FDA |
| Hemangioblastoma | 4 | D018325 | FDA |
| von Hippel-Lindau Disease | 4 | D006623 | FDA |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4585668 |
| FDA SRS | 7K28NB895L |
| Guide to Pharmacology | 11251 |
| PDB | 72Q |
| PubChem | 117947097 |
| SureChEMBL | SCHEMBL16560918 |
| ZINC | ZINC000584905085 |